Now showing items 378-397 of 637

      Nanocarrier vaccines for SARS-CoV-2 [1]
      A Nation-wide Review of Elective Surgery and COVID-Surge Capacity [1]
      National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines. [1]
      The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections [1]
      Navigating COVID-19 Testing: Special Considerations for the Cardiovascular Clinician [1]
      A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses [1]
      Next steps in long term care: How can nursing help? [1]
      Novel Insights Into Immune Systems of Bats [1]
      A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers [1]
      A Novel Stability-Indicating HPLC-DAD Method for Determination of Favipiravir, a Potential Antiviral Drug for COVID-19 Treatment; Application to Degradation Kinetic Studies and In-Vitro Dissolution Profiling [1]
      The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development [1]
      Nursing home visitation restrictions during COVID-19-Balancing compassion and safety [1]
      NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. [1]
      Older Adults’ Intention to Socially Isolate Once COVID-19 Stay-at-Home Orders Are Replaced With “Safer-at-Home” Public Health Advisories: A Survey of Respondents in Maryland [1]
      On the Move or Barely Moving? Age-Related Changes in Physical Activity, Sedentary, and Sleep Behaviors by Weekday/Weekend Following Pandemic Control Policies. [1]
      One dose of COVID-19 nanoparticle vaccine REVC-128 provides protection against SARS-CoV-2 challenge at two weeks post immunization [1]
      One-Health: A safe, efficient, dual-use vaccine for humans and animals against middle east respiratory syndrome coronavirus and rabies virus [1]
      Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development. [1]
      Opportunities and Challenges in North-South and South-South Global Health Collaborations During the COVID-19 Pandemic: The AFREhealth-CUGH Experience (as Reported at the CUGH 2021 Satellite Meeting) [1]
      Optimal COVID-19 quarantine and testing strategies. [1]